Results 221 to 230 of about 195,924 (307)

Radiomics-based model for predicting neoadjuvant therapy response in esophageal cancer: Limitations and suggestions. [PDF]

World J Gastrointest Oncol
Zhao ZX.
europepmc   +1 more source

Surgical Management of Recurrent Retroperitoneal Sarcomas: Experience From a High‐Volume Sarcoma Centre

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background Retroperitoneal sarcoma (RPS) is a rare and complex malignancy, requiring specialized multidisciplinary care. While a significant progress has been made in managing a primary RPS, there is a limited literature on the outcomes of recurrent RPS (RecRPS).
Abdeali Saif Arif Kaderi, Tanvi M. Shah, Shraddha Patkar, Y. Aditya Sai Ram, Vinayaka S. Bairannavar, M. Myvizhi Kannan, Bharat Rekhi, Prabhat Bhargav, Kunal B. Gala, Afroj Bagwan, Mukta Ramadwar, Jifmi Jose, Nehal Khanna, Siddhartha Laskar, Mahesh Goel   +14 more
wiley   +1 more source

Optimising response assessment to neoadjuvant therapy in rectal cancer to reduce the incidence of ypT0N0 resection. [PDF]

Int J Colorectal Dis
Hew J, Mohtashami A, Mastrocostas K, Skinner T, De Silva K, Pavlakis N, Hruby G, Evans J, Salama Y, Kneebone A, Chang KH.   +10 more
europepmc   +1 more source

Post‐Radiation Granuloma Annulare: A Series of Three Cases

JEADV Clinical Practice, EarlyView.
ABSTRACT We report typical cases of biopsy confirmed granuloma annulare occurring on irradiated skin in the context of breast cancer in three women in their seventies. The lesions appeared immediately after start of irradiation in one patient, 4 and 15 months after the end of radiation treatment in the other two. The lesions eventually spread elsewhere
Léa Scheid, Mona Mitcov, Dan Lipsker
wiley   +1 more source

Gastrointestinal Toxicity and Clinical Predictors of Total Neoadjuvant Therapy in Rectal Cancer: A Real-World Retrospective Study. [PDF]

Life (Basel)
Bratu LD, Stovicek PO, Ciurea AM, Mehedințeanu AM, Berisha TC, Schenker RA, Dicianu AM, Stamulescu C, Paitici Ș, Mogoantă SȘ, Schenker M.   +10 more
europepmc   +1 more source

Circ_0006174 Drives Triple Negative Breast Cancer Progression and Immune Escape Through Regulating miR‐3139/PD‐L1 Axis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Triple‐negative breast cancer (TNBC) is characterized as an aggressive malignancy with limited therapeutic options. The circular RNA circ_0006174 has been implicated in oncogenic processes across various cancers; however, its specific role in the pathogenesis of TNBC remains unclear.
Yong‐Zhe Tang, Li Yang, Ling Wang, Xiao‐Qing Zhang, Jie Wang   +4 more
wiley   +1 more source

Survival Outcomes in Patients With Locally Advanced NSCLC Converted to Resectable Disease by Neoadjuvant Therapy. [PDF]

In Vivo
Gulsen ED, Ismayilov R, Farzaliyeva A, Ramazanoglu MN, Oguz A, Kilic D, Akcali Z, Altundag O.   +7 more
europepmc   +1 more source

Robotic‐Assisted Versus Laparoscopic‐Assisted Colectomy: Findings on Short‐Term Outcomes From A Multi‐Institutional Propensity Score‐Matched Study

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT The present study compared the short‐term outcomes and perioperative complications of robotic‐assisted colectomy (RAC) and laparoscopic‐assisted colectomy (LAC) in patients with colon cancer. This retrospective study included patients with histologically confirmed colon adenocarcinoma who underwent either RAC or LAC at five medical centers in ...
Ching‐Wen Huang, Chien‐Chih Chen, Jeng‐Fu You, Yi‐Ho Cheng, Feng‐Fan Chiang, Jaw‐Yuan Wang   +5 more
wiley   +1 more source

Bridging Clinical Trials to Real-World Clinical Practice: TCHP Neoadjuvant Therapy Outcomes in HER2-Positive Breast Cancer. [PDF]

Breast Cancer (Dove Med Press)
Sharaf B, Seif A, Bani Hani H, Alhasan M, Khader R, Al-Yag'oub M, Ghanem A, Bani Ata J, Ajlouni B, Jawarneh Q, Jaffal A, Tamimi F, Jehad S, Al-Abdallat H, Mahafdah O, Abdel-Razeq H.   +15 more
europepmc   +1 more source

Risk Factors Influencing Efficacy and Prognosis Evaluation of Neoadjuvant Systemic Therapy in Triple‐Positive Breast Cancer

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT To identify the determinants of the response to neoadjuvant systemic therapy (NST) in triple‐positive breast cancer (TPBC), we retrospectively enrolled 520 patients with human epidermal growth factor receptor 2 (HER2)‐positive breast cancer who were treated at The First Affiliated Hospital of Chongqing Medical University between January 2015 ...
Lin‐Rui Miao, Hao Liu, Hai‐Ying Yu, Jian Chen, Ming‐Yu Yang, Ya‐Lan Zhang, Gang Tu, Ling‐Feng Tang   +7 more
wiley   +1 more source